新城疫病毒F蛋白细胞融合活性位点中保守氨基酸基因突变分析

为了确定新城疫病毒融合蛋白(F)分子上活性位点中保守氨基酸在F蛋白的细胞融合作用,弄清F细胞融合的分子机理,采用基因定点突变法,创造一个酶切位点,用酶切反应初步筛选突变株,然后用DNA序列分析进一步确定,并于真核细胞内进行表达,Giemsa染色定性和指示基因法定量检测细胞融合功能,荧光强度分析(FACS)检测表达效率情况。结果表明,NDV F第117位苯丙氨酸(F)突变成亮氨酸(L)时对细胞融合作用没有显著影响。R112和K115同为保守序列,分别突变为G时,细胞融合活性只有原来的44%,下降了56%。细胞表面表达效率没有明显的改变。N147突变为K时,细胞融合活性明显下降,只有原来的15%,而细胞表面表达效率没有明显的改变。L154为保守序列,突变为K时,细胞融合活性消失,说明L154是一个非常关键的氨基酸,对维持F蛋白的细胞融合活性非常重要。细胞表面表达效率也有所下降(为原来的94%)。D462属于高度保守氨基酸,当突变为N时,细胞融合活性消失,但经细胞表面表达效率分析证明,此突变蛋白未表达于细胞表面,证明在细胞浆转运至细胞表面的过程中发生了问题。当突变为R和E时,细胞融合活性未发生改变,但细胞表面表达效率有所下降,分别为野毒株的63%和44%。说明NDV F分子上与HN相互作用的特异性区域中的某些保守氨基酸在细胞融合中发挥着重要作用,对F蛋白的折叠、加工、转运等,发挥着不同作用,从而影响F蛋白的细胞融合作用和/或在细胞表面的表达量。     

用Bac-to-Bac杆状病毒表达系统高效表达绿色荧光蛋白标记的HBVe抗原

通过基因工程操作,使乙型肝炎病毒ｅ抗原（ＨＢｅＡｇ）基因与绿色荧光蛋白基因（ＧＦＰ）融合,用新型Ｂａｃ－ｔｏ－Ｂａｃ杆状病毒表达系统在昆虫细胞中高效表达了ＨＢｅＡｇ－ＧＦＰ双功能融合蛋白。经ＥＬＩＳＡ法和荧光显微镜观察证实,表达产物既能发射易于检测的绿色荧光,又具有ＨＢＶ的ｅ抗原活性,为免疫诊断新方法的建立进行了有益的探索     

用Bac—to—Bac杆状病毒表达系统高效表达绿色荧光蛋白标记的HBVe抗原

通过基因工程操作,使乙型肝炎病毒ｅ抗原（ＨＢｅＡｇ）基因与绿色荧光蛋白基因（ＧＦＰ）融合,用新型Ｂａｃ－ｔｏ－Ｂａｃ杆状病毒表达系统在昆虫细胞中高效表达了ＨＢｅＡｇ－ＧＦＰ双功能融合蛋白。经ＥＬＩＳＡ法和荧光显微镜观察证实,表达产物既能发射易于检测的绿色荧光,又具有ＨＢＶ的ｅ抗原活性,为免疫诊断新方法的建立进行了有益的探索。     

基因重组人肿瘤坏死因子-α突变体的构建

在详细分析ＴＮＦ α结构及有关ＴＮＦ α结构与功能关系研究的基础上,设计并人工合成了一对ＴＮＦ α结构基因点突变引物。应用ＰＣＲ和分子克隆技术构建了一种新型人肿瘤坏死因子（ＴＮＦ α）分子的编码基因,将该编码基因插入表达质粒,转化大肠杆菌,通过温度诱导获得了表达蛋白,对突变体克隆进行了ＤＮＡ电泳、酶切位点检测以及基因序列测定,并对突变体蛋白进行了ＳＤＳ ＰＡＧＥ电泳检测。     

野生型及启动子区突变的HPFHAγ基因在MEL细胞中的表达

研究了野生型Ａγ珠蛋白基因、中国型胎儿血红蛋白持续存在综合症（ＨＰＦＨ）Ａγ基因（启动子区─１９６Ｃ→Ｔ突变）及希腊型ＨＰＦＨＡγ基因（─１１７Ｇ→Ａ突变）在鼠红白血病（ＭＥＬ）ＧＭ９７９细胞中的表达。比较每个整合的Ａγ基因表达的ｍＲＮＡ量,─１９６Ｃ→Ｔ突变Ａγ基因未显示比野生型Ａγ基因明显增加的表达水平,而─１１７Ｇ→Ａ突变Ａγ基因在未分化的及ＨＭＢＡ或丁酸钠诱导分化的ＭＥＬＧＭ９７９细胞中的表达水平增加到野生型Ａγ基因相应水平的２．３倍至３．１倍。此结果提供了又一个实验证据,说明启动子─１１７Ｇ→Ａ突变是希腊型ＨＰＦＨ中胎儿Ａγ基因在成人中持续活跃表达的原因,这也为β地中海贫血和镰刀性贫血的基因治疗提供了新途径,即可以考虑用转移─１１７Ｇ→Ａ突变Ａγ基因的方法改善患者的贫血症状。     

美洲拟鲽抗冻肽基因在E.coli中的表达

动物抗冻肽（ＡＦＰ）以降低动物体液冰点而使其能在寒冷的环境中生活,因而ＡＦＰ在防寒抗冻方面有较大的潜力。根据美洲拟鲽ＡＦＰ基因的ｃＤＮＡ序列,人工合成了ＡＦＰ及春含前导序列的ｐｒｏＡＦＰ的ｃＤＮＡ,并构建成ＰＡＦＰ及ＰＰＡＦＰ原核表达载体。由于ＡＦＰ表达量少且蛋白分子很小,用ＳＤＳ－蛋白电泳难以检测。为了提高检测的灵敏度,把报道基因ＣＡＴ的ＣＤＮＡ按读码框连接到ＡＦＰ的３＇末端,构建成融合基因表达     

马铃薯Y病毒NIb复制酶基因在转录水平介导的相对广谱抗病性

在大肠杆菌中表达了马铃薯Ｙ病毒中国分离物（ＰＶＹ－Ｃ）复制酶ＮＩｂ基因,并制备了其抗血清。利用ＰＣＲ定点突变方法使ＮＩｂ基因移码－１位,构建了移码－１位ＮＩｂ基因（ＵＮ）的植物表达载体。通过土壤农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ ｔｕｍｅｆａｃｉｅｎｓ ＬＢＡ４４０４）介导转化烟草ＮＣ８９,获得５１株再生植株。对再生植株的分子检测结果表明,转基因烟草中检测到ＵＮ基因相应的ＲＮＡ转录产物,３推测该基     

野生型及启动子区突变的HPFHAγ基因在MEL细胞中的表达

研究了野生型Ａγ珠蛋白基因、中国型胎儿血红蛋白持续存在综合症（ＨＰＦＨ）Ａγ基因（启动子区－１９６Ｃ－Ｔ突变）及希腊型ＨＰＦＨＡγ基因（－１１７Ｇ－Ａ突变）在鼠红白血病（ＭＥＬ）ＧＭ９７９细胞中的表达,比较每个整合的Ａγ基因明显增加的表达水平,而－１１７Ｇ－Ａ１９６Ｃ－Ｔ突变Ａγ基因未显示比野生型Ａγ基因明显增加的表达水平,而－１１７Ｇ－Ａ空变Ａγ基因在未分化的及ＨＭＢＡ或丁酸钠诱导分化的ＭＥＬＧ     

重组人肿瘤坏死因子α和白细胞介素6融合基因的构建和表达

本文利用ＰＣＲ技术和基因定位突变技术,将编码人肿瘤坏死因子α（ｈＴＮＦα）和白细胞介素６（ｈＩＬ－６）成熟肽的基因通过中间接头连接成编码单一蛋白的基因,构建了融合蛋白表达载体ｐＢＩＴ,并在大肠杆菌中得到了表达。ＳＤＳ－ＰＡＧＥ的电泳胶薄层扫描显示,融合蛋白的表达量是菌体总蛋白量的２０％,其分子量约为３７ｋＤ。活性检测证实,融合蛋白既有ＴＮＦ活性,又有ＩＬ－６活性。     

小干扰RNA干扰缺氧诱导因子-1alpha增强口腔鳞癌细胞株化疗敏感性

目的：探讨针对缺氧诱导因子－１α（ＨＩＦ－１α）的小干扰ＲＮＡ（ｓｉＲＮＡ）对口腔鳞癌细胞（ＯＳＣＣ）化疗敏感性的影响。方法：用Ｗｅｓｔｅｒｎ印迹检测ＯＳＣＣ和针对ＨＩＦ－１α基因的ｓｉＲＮＡ导入ＯＳＣＣ后的ＨＩＦ－１α蛋白表达水平;用ＭＴＴ法检测细胞对化疗敏感性的影响;用流式细胞术检测化疗诱导细胞凋亡的凋亡率。结果：ＨＩＦ－１α在ＯＳＣＣ中高表达,ＨＩＦ－１α－ｓｉＲＮＡ转染后ＨＩＦ－１α表达水平明显下降,细胞对化疗敏感性明显提高,化疗诱导肿瘤细胞凋亡率明显增加。结论：针对ＨＩＦ－１α基因的ｓｉＲＮＡ能明显降低ＨＩＦ－１α的表达,增强化疗对ＯＳＣＣ的凋亡诱导作用,有效提高ＯＳＣＣ对化疗的敏感性。     

副粘病毒F1蛋白胞外非保守区对其特异性膜融合的影响

为了解融合蛋白F1分子的胞外非保守区在融合蛋白(F)与血凝素．神经氨酸酶(HN)的特异性膜融合中的作用,采用基因定点突变方法,在新城疫病毒(NDV)F1与人副流感病毒(hPIV)F1基因的胞外非保守区进行定点突变,创造酶切位点,得到分别含3个相同酶切位点的突变株NDV-M和hPIV-M。经检测,突变体的细胞融合功能与野毒株相同。然后用3个限制性内切酶分别从NDV-M与hPIV-M中切出两个片段NDVF-1、F-2及hPIVF-1、F-2。NDV-M和hPIV-M相互交换对应的F-1片段后进行基因重组,得到2个嵌合体(Chimera),即NDV-C1和hPIV-C1;同样方法交换F-2片段后又得到2个嵌合体NDV-C2和hPIV-C2。将各种嵌合体DNA与同源及异源HN基因共转染BHK21细胞后,在真核细胞中表达。Giemsa染色和指示基因法检测细胞融合功能,荧光强度分析(FACS)检测F蛋白的表达效率。结果表明,突变体：NDV-M和hPIV-M的细胞融合功能与野毒株相同,可用于构建嵌合体。NDV-1C和NDV—C2分别与NDV HN共表达后,融合功能达到野毒株的76．34％和96．2％,与hPIV HN共表达后均无细胞融合发生;hPIV-C1和hPIV—C2分别与hPIV HN共表达后,融合功能达到野毒株的65．82％和93．78％,与NDV HN共表达后无细胞融合发生。FACS分析表明,突变体及所有嵌合体蛋白F的表达效率与野毒株相比均没有明显变化。实验结果说明在F1蛋白的胞外非保守区中,NDV F-1和hPIV F-1这两个片段对于NDV和hPIV的特异性膜融合具有重要作用;而NDV F-2和hPIV F-2这两个片段对于NDV和hPIV的膜融合来讲,则特异性较低。     

Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein.

The paramyxovirus fusion proteins have a highly conserved leucine zipper motif immediately upstream from the transmembrane domain of the F1 subunit (R. Buckland and F. Wild, Nature [London] 338:547, 1989). To determine the role of the conserved leucines in the oligomeric structure and biological activity of the Newcastle disease virus (NDV) fusion protein, the heptadic leucines at amino acids 481, 488, and 495 were changed individually and in combination to an alanine residue. While single amino acid changes had little effect on fusion, substitution of two or three leucine residues abolished the fusogenic activity of the protein, although cell surface expression of the mutants was higher than that of the wild-type protein. Substitution of all three leucine residues with alanine did not alter the size of the fusion protein oligomer as determined by sedimentation in sucrose gradients. Furthermore, deletion of the C-terminal 91 amino acids, including the leucine zipper motif and transmembrane domain, resulted in secretion of an oligomeric polypeptide. These results indicate that the conserved leucines are not necessary for oligomer formation but are required for the fusogenic ability of the protein. When the polar face of the potential alpha helix was altered by nonconservative changes of serine to alanine (position 473), glutamic acid to lysine or alanine (position 482), asparagine to lysine (position 485), or aspartic acid to alanine (position 489), the fusogenic ability of the protein was not significantly disrupted. In addition, a double mutant (E482A,D489A) which removed negative charges along one side of the helix had negligible effects on fusion activity.     

Characterization of modeled inhibitory binding sites on isoform one of the Na+/H+ exchanger

Mammalian Na⁺/H⁺ exchanger isoform one (NHE1) is a plasma membrane protein responsible for pH regulation in mammalian cells. Excess activity of the protein promotes heart disease and is a trigger of metastasis in cancer. Inhibitors of the protein exist but problems in specificity have delayed their clinical application. Here we examined amino acids involved in two modeled inhibitor binding sites (A, B) in human NHE1. Twelve mutations (Asp159, Phe348, Ser351, Tyr381, Phe413, Leu465, Gly466, Tyr467, Leu468, His473, Met476, Leu481) were made and characterized. Mutants S351A, F413A, Y467A, L468A, M476A and L481A had 40–70% of wild type expression levels, while G466A and H473A expressed 22% ~ 30% of the wild type levels. Most mutants, were targeted to the cell surface at levels similar to wild type NHE1, approximately 50–70%, except for F413A and G466A, which had very low surface targeting. Most of the mutants had measurable activity except for D159A, F413A and G466A. Resistance to inhibition by EMD87580 was elevated in mutants F438A, L465A and L468A and reduced in mutants S351A, Y381A, H473A, M476A and L481A. All mutants with large alterations in inhibitory properties showed reduced Na⁺ affinity. The greatest changes in activity and inhibitor sensitivity were in mutants present in binding site B which is more closely associated with TM4 and C terminal of extracellular loop 5, and is situated between the putative scaffolding domain and transport domain. The results help define the inhibitor binding domain of the NHE1 protein and identify new amino acids involved in inhibitor binding.     

Listeria monocytogenes Mutants Carrying Newcastle Disease Virus F Gene Fused to its actA and plcB： In vitro Expression and Immunogenicity in Chickens

Recombinant Listeria monocytogenes mutants carrying Newcastle disease virus (NDV) fusionprotein gene F were constructed by homologous recombination.NDV F or its truncated fragment Fa wasused as the model heterologous gene to be integrated into actA or plcB downstream of their signal sequences.Correct orientation of the inserted genes was verified by polymerase chain reaction amplification of F or Fa.The inserted F and Fa were expressed in the two recombinants Lm-AactA-F and Lm-AplcB-Fa as shown bysodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot.Both recombinantsexhibited reduced virulence to embryonated eggs and mice by about 1.5-2.5 logs as compared with theparent wild strain 10403S. They were also less invasive than strain 10403S (P<0.05). Chickens receiving therecombinant strains orally or intraperitoneally were partially protected from virulent NDV challenge possiblydue to enhancement of non-specific immunity because the antibody titers against the homologous virus strainor the recombinant truncated fusion protein were marginal. Further research is needed in other animal modelsto see if the low antibody response results from insufficient expression of the heterologous genes as a resultof failure of L. monocytogenes or its recombinants to persist or replicate in chickens.     

Comparison of substrate specificities against the fusion glycoprotein of virulent Newcastle disease virus between a chick embryo fibroblast processing protease and mammalian subtilisin-like proteases

The fusion (F) protein precursor of virulent Newcastle disease virus (NDV) strains has two pairs of basic amino acids at the cleavage site, and its intracellular cleavage activation occurs in a variety of cells; therefore, the viruses cause systemic infections in poultry. To explore the protease responsible for the cleavage in the natural host, we examined detailed substrate specificity of the enzyme in chick embryo fibroblasts (CEF) using a panel of the F protein mutants at the cleavage site expressed by vaccinia virus vectors, and compared the specificity with those of mammalian subtilisin-like proteases such as furin, PC6 and PACE4 which are candidates for F protein processing enzymes. It was demonstrated in CEF cells that Arg residues at the -4, -2 and -1 positions upstream of the cleavage site were essential, and that at the -5 position was required for maximal cleavage. Phe at the +1 position was also important for efficient cleavage. On the other hand, furin and PC6 expressed by vaccinia virus vectors showed cleavage specificities against the F protein mutants consistent with that shown by the processing enzyme of CEF cells, but PACE4 hardly cleaved the F proteins including the wild type. These results indicate that the proteolytic processing enzymes of poultry for virulent NDV F proteins could be furin and/or PC6 but not PACE4. The significance of individual contribution of the three amino acids at the -5, -2 and +1 positions to cleavability was discussed in relation to the evolution of virulent and avirulent NDV strains.     

非特异性脂质转移蛋白突变体的构建及在两种硫氧还蛋白表达载体中的表达比较

对水稻非特异性脂质转移蛋白(Nospecific lipid transfer protein,nsLTP) LTP110中结构重要的5个氨基酸位点进行了定点突变,测序结果证实了突变体构建成功。在尝试了多种大肠杆菌表达系统进行表达之后,发现硫氧还蛋白融合表达载体适合于LTP110野生型及突变体的表达。将编码野生型LTP110及突变体Y17A,P72L,R46A,D45A,C50A蛋白的cDNA顺序克隆进两种硫氧还蛋白表达载体并对其表达情况进行了比较：pTrxFus载体可以在宿主菌GI724中以较低水平表达野生型LTP110及突变体Y17A,P72L,R46A融合蛋白,但不能表达D45A和C50A融合蛋白;pET32a(+)载体可以在宿主菌BL21 (DE3) trxB-中以可溶蛋白的形式表达野生型及所有突变型融合蛋白,且表达量比在pTrxFus载体/GI724突主菌中表达量高。对pET32a(+)载体中表达的LTP110融合蛋白进行了纯化,并利用带有荧光标记的脂肪酸分子对其测活,结果表明表达的野生型LTP110分子具有结合脂质的活性。     

A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion

The role of a leucine heptad repeat motif between amino acids 268 and 289 in the structure and function of the Newcastle disease virus (NDV) F protein was explored by introducing single point mutations into the F gene cDNA. The mutations affected either folding of the protein or the fusion activity of the protein. Two mutations, L275A and L282A, likely interfered with folding of the molecule since these proteins were not proteolytically cleaved, were minimally expressed at the cell surface, and formed aggregates. L268A mutant protein was cleaved and expressed at the cell surface although the protein migrated slightly slower than wild type on polyacrylamide gels, suggesting an alteration in conformation or processing. L268A protein was fusion inactive in the presence or absence of HN protein expression. Mutant L289A protein was expressed at the cell surface and proteolytically cleaved at better than wild-type levels. Most importantly, this protein mediated syncytium formation in the absence of HN protein expression although HN protein enhanced fusion activity. These results show that a single amino acid change in the F(1) portion of the NDV F protein can alter the stringent requirement for HN protein expression in syncytium formation.     

The role of the carboxyl terminal alpha-helical coiled-coil domain in osmosensing by transporter ProP of Escherichia coli

Concentrative uptake of osmoprotectants via transporter ProP contributes to the rehydration of Escherichia coli cells that encounter high osmolality media. A member of the major facilitator superfamily, ProP is activated by osmotic upshifts in whole bacteria, in cytoplasmic membrane vesicles and in proteoliposomes prepared with the purified protein. Soluble protein ProQ is also required for full osmotic activation of ProP in vivo. ProP is differentiated from structural and functional homologues by its osmotic activation and its C-terminal extension, which is predicted to form an alpha-helical coiled-coil. A synthetic polypeptide corresponding to the C-terminus of ProP (ProP-p) formed a dimeric alpha-helical coiled-coil. A derivative of transporter ProP lacking 26 C-terminal amino acids was expressed but inactive. A derivative harbouring amino acid changes K460I, Y467I and H495I (each at the core, coiled-coil 'a' position) required a larger osmotic upshift for activation than did the wild type transporter. The same changes extended, stabilized and altered the oligomeric state of the coiled-coil formed by ProP-p. Amino acid change R488I (also at the 'a' position) further increased the magnitude of the osmotic upshift required to activate ProP, reduced the activity attained and rendered ProP activation transient. Unexpectedly, replacement R488I destabilized the coiled-coil formed by ProP-p. The activity and osmotic activation of ProP were even more strongly attenuated by helix-destabilizing change I474P. These data demonstrate that the carboxyl terminal domain of ProP can form a homodimeric alpha-helical coiled-coil with unusual properties. They implicate the C-terminal domain in the osmotic activation of ProP.     

Possible involvement of a cell surface glycoprotein in the differentiation of skeletal myoblasts

From a highly myogenic permanent line of rat skel-myoblasts (L6), we have isolated two classes of single step concanavalin A-resistant mutants. The RI class is about 2-fold and RII about 5-fold more resistant than the parental cells to the lethal action of concanavalin A. In all of the mutants, both the morphological differentiation (i.e. fusion to form myotubes) and biochemical differentiation, measured by the appearance of creatine kinase and acetylcholine receptors, are absent. The biochemical lesion in the RI type of mutants is not known, but RII type of mutants is unable to catalyze transfer of mannose from GDP-mannose into a lipid-linked form. Concanavalin A binding to separated membrane proteins from RII type of mutants on polyacrylamide gels is reduced 80% compared to wild type cells. In the RI type of mutants, however, only one major band, approximately 46,000 daltons, does not bind concanavalin A to the same extent as the wild type cells. In somatic cell hybridizations, RI type of mutants complements the RII type. In the hybrids, fusion as well as creatine kinase and acetylcholine receptors reappear, although not to the same extent as in the wild type cells. The 46,000-dalton band also reappears in the complementing hybrids. Thus, this protein may play some crucial role in myogenesis.